Primary Mediastinal Large B-Cell Lymphoma-Refractory Clinical Trials

4 clinical trials for Primary Mediastinal Large B-Cell Lymphoma-Refractory across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Study to Evaluate the Safety and Clinical Activity of GF- CART01 (CD20/19 CAR T Cell) in Subjects With Relapsed or Refractory B-Cell Hematological Malignancies — RECRUITING · PHASE1
• Pembro Plus CAR T-cell Therapy in R/R in PMBCL — RECRUITING · PHASE2
• CC-99282 + Rituximab Early Post CART for Non-Hodgkin's Lymphoma — RECRUITING · PHASE1
• A Study to Evaluate the Safety and Efficacy of Pembrolizumab (MK-3475) Coformulated With Berahyaluronidase Alfa (MK-3475A) in Participants With Relapsed or Refractory Classical Hodgkin Lymphoma (rrcHL) or Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma (rrPMBCL)(MK-3475A-F65) — ACTIVE_NOT_RECRUITING · PHASE2

Refine this search